{"id":562967,"title":"Notice - Revision to Guidance Document: Submission of Pharmacogenomic Information - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-02-16","captureTimestamp":"2026-02-16T10:44:17.605000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/applications-submissions/guidance-documents/submission-pharmacogenomic-information.html","snippet":"Notice - Revision to Guidance Document: Submission of Pharmacogenomic Information (PDF Version - 445 K) Contact: BGTD Regulatory Affairs Division August 13, 2008 Our file number: 08-108225-127 Table of Contents 1.0 Introduction 1.1 Objectives 1.2 Scope and Application 1.3 Policy…","rawSnapshotUrl":"/api/snapshots/raw/562967","browseUrl":"https://replay.healtharchive.ca/job-6/20260216104417/https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/applications-submissions/guidance-documents/submission-pharmacogenomic-information.html#ha_snapshot=562967","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}